Alexandra Kent

2.1k total citations
33 papers, 232 citations indexed

About

Alexandra Kent is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Alexandra Kent has authored 33 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Alexandra Kent's work include Inflammatory Bowel Disease (14 papers), Pregnancy and Medication Impact (7 papers) and Eosinophilic Esophagitis (4 papers). Alexandra Kent is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Pregnancy and Medication Impact (7 papers) and Eosinophilic Esophagitis (4 papers). Alexandra Kent collaborates with scholars based in United Kingdom, United States and Zambia. Alexandra Kent's co-authors include Annette Maznyczka, Vijay Kunadian, Peter T. Campbell, Matthew Banks, Simon Greenfield, Catherine Nelson‐Piercy, Klaartje Kok, Aileen Fraser, Jimmy K. Limdi and David Woolf and has published in prestigious journals such as Gastroenterology, Gut and Annals of the Rheumatic Diseases.

In The Last Decade

Alexandra Kent

25 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Kent United Kingdom 7 76 71 48 48 42 33 232
Koji Nanmoku Japan 12 135 1.8× 84 1.2× 67 1.4× 27 0.6× 46 1.1× 40 402
Laura Sandler United States 7 72 0.9× 56 0.8× 60 1.3× 56 1.2× 24 0.6× 8 559
Halil Gürsoy Pala Türkiye 11 59 0.8× 92 1.3× 33 0.7× 50 1.0× 26 0.6× 57 369
M. Ciroldi France 5 39 0.5× 71 1.0× 111 2.3× 27 0.6× 63 1.5× 7 292
Babür Kaleli̇ Türkiye 13 94 1.2× 134 1.9× 78 1.6× 31 0.6× 23 0.5× 28 498
Genel Sur Romania 11 79 1.0× 34 0.5× 101 2.1× 28 0.6× 26 0.6× 51 357
H. Hedri Tunisia 11 108 1.4× 52 0.7× 38 0.8× 15 0.3× 48 1.1× 60 345
É. Thervet France 7 175 2.3× 69 1.0× 68 1.4× 15 0.3× 62 1.5× 18 406
Elen Almeida Romão Brazil 10 37 0.5× 23 0.3× 44 0.9× 26 0.5× 20 0.5× 38 325
José Maté Spain 9 108 1.4× 33 0.5× 53 1.1× 19 0.4× 60 1.4× 20 288

Countries citing papers authored by Alexandra Kent

Since Specialization
Citations

This map shows the geographic impact of Alexandra Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Kent more than expected).

Fields of papers citing papers by Alexandra Kent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Kent. The network helps show where Alexandra Kent may publish in the future.

Co-authorship network of co-authors of Alexandra Kent

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Kent. A scholar is included among the top collaborators of Alexandra Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Kent. Alexandra Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rak, Arkadiusz, P Dubois, Abdul Hakeem, et al.. (2025). P1172 Real world experience using advanced therapies to treat Inflammatory Bowel Disease in patients with a Liver Transplant. Journal of Crohn s and Colitis. 19(Supplement_1). i2134–i2135.
2.
Watson, N, Joel Mawdsley, Alexandra Kent, et al.. (2025). P0850 Managing pain in people with Crohn’s Disease: feasibility testing of an Acceptance and Commitment Group Therapy intervention. Journal of Crohn s and Colitis. 19(Supplement_1). i1621–i1622.
4.
Selinger, Christian P., Robyn Laube, Jimmy K. Limdi, et al.. (2024). Appropriateness of small molecule agents for patients with IBD of childbearing age – a RAND/UCLA appropriateness panel. Therapeutic Advances in Gastroenterology. 17. 1118482713–1118482713. 2 indexed citations
5.
Hayee, Bu, et al.. (2024). P455 Deploying machine learning algorithms to stratify patients with inflammatory bowel disease using routinely collected electronic health records. Journal of Crohn s and Colitis. 18(Supplement_1). i913–i913. 1 indexed citations
6.
7.
Alexander, James L., Zhigang Liu, Hajir Ibraheim, et al.. (2023). P75 Vaccine-induced antibody responses against influenza are diminished in infliximab and tofacitinib-treated IBD patients and correlate with responses to COVID-19 vaccination. Poster presentations. A88.1–A88. 1 indexed citations
8.
Coates, Laura C., Marwan Bukhari, Antoni Chan, et al.. (2023). POS0077-HPR ENHANCING CURRENT GUIDANCE FOR PSORIATIC ARTHRITIS AND ITS COMORBIDITIES: RECOMMENDATIONS FROM AN EXPERT CONSENSUS PANEL OF HEALTHCARE PROFESSIONALS IN THE UK. Annals of the Rheumatic Diseases. 82. 250–250. 1 indexed citations
9.
Selinger, Christian P., Klaartje Kok, Jimmy K. Limdi, et al.. (2022). Live vaccinations for infants exposed to maternal infliximab in utero and via breast milk – the need for nuanced decision making. BMJ Open Gastroenterology. 9(1). e001029–e001029. 3 indexed citations
10.
Sebastian, Shaji, Jonathan Segal, Sreedhar Subramanian, et al.. (2022). Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study. BMJ Open Gastroenterology. 9(1). e000763–e000763. 6 indexed citations
11.
Saifuddin, Aamir, Alexandra Kent, Shameer Mehta, et al.. (2022). Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD multicentre cohort study. Alimentary Pharmacology & Therapeutics. 56(10). 1460–1474. 3 indexed citations
12.
Limdi, Jimmy K., Christian P. Selinger, Paul Blaker, et al.. (2021). A ‘real‐world’ retrospective multi‐centre cohort study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis. 3(4). 229–235. 1 indexed citations
13.
Selinger, Christian P., Aileen Fraser, Paul Collins, et al.. (2021). Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD. BMJ Open Gastroenterology. 8(1). e000603–e000603. 6 indexed citations
14.
Basuroy, Ron, et al.. (2018). Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 107(1). 42–49. 24 indexed citations
15.
Keshav, Satish & Alexandra Kent. (2018). Prevention of gastrointestinal disease. Oxford University Press eBooks.
17.
Campbell, Peter T., et al.. (2014). Obesity and cardiovascular outcomes: a review. European Heart Journal Acute Cardiovascular Care. 5(1). 77–85. 74 indexed citations
18.
Kent, Alexandra, et al.. (2012). What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?. Current Drug Delivery. 9(4). 356–366. 5 indexed citations
19.
Kent, Alexandra & Matthew Banks. (2010). Pharmacological Management of Diarrhea. Gastroenterology Clinics of North America. 39(3). 495–507. 16 indexed citations
20.
Kent, Alexandra, et al.. (2009). The use of symptoms to predict colorectal cancer site. Can we reduce the pressure on our endoscopy services?. Colorectal Disease. 12(2). 114–118. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026